Royal Bank of Canada’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,776
| Closed | -$10K | – | 7882 |
|
|
2023
Q2 | $10K | Buy |
4,776
+4,276
| +855% | +$8.87K | ﹤0.01% | 6496 |
|
|
2023
Q1 | $1K | Sell |
500
-415
| -45% | -$820 | ﹤0.01% | 6987 |
|
|
2022
Q4 | $2K | Sell |
915
-300
| -25% | -$748 | ﹤0.01% | 6973 |
|
|
2022
Q3 | $3K | Buy |
1,215
+715
| +143% | +$1.78K | ﹤0.01% | 6954 |
|
|
2022
Q2 | $1K | Sell |
500
-3,006
| -86% | -$6.56K | ﹤0.01% | 7269 |
|
|
2022
Q1 | $10K | Sell |
3,506
-8,585
| -71% | -$32.3K | ﹤0.01% | 6963 |
|
|
2021
Q4 | $54K | Buy |
12,091
+6,658
| +123% | +$31.6K | ﹤0.01% | 6341 |
|
|
2021
Q3 | $26K | Buy |
5,433
+1,799
| +50% | +$9.91K | ﹤0.01% | 6562 |
|
|
2021
Q2 | $24K | Sell |
3,634
-470
| -11% | -$3.8K | ﹤0.01% | 6481 |
|
|
2021
Q1 | $29K | Sell |
4,104
-617
| -13% | -$4.44K | ﹤0.01% | 6217 |
|
|
2020
Q4 | $29K | Buy |
4,721
+3,154
| +201% | +$18.6K | ﹤0.01% | 5899 |
|
|
2020
Q3 | $9K | Sell |
1,567
-187
| -11% | -$926 | ﹤0.01% | 5974 |
|
|
2020
Q2 | $10K | Sell |
1,754
-3,062
| -64% | -$13.6K | ﹤0.01% | 5846 |
|
|
2020
Q1 | $16K | Sell |
4,816
-350
| -7% | -$1.29K | ﹤0.01% | 5648 |
|
|
2019
Q4 | $21K | Buy |
5,166
+3,844
| +291% | +$13.3K | ﹤0.01% | 5837 |
|
|
2019
Q3 | $6K | Buy |
1,322
+656
| +98% | +$2.62K | ﹤0.01% | 5986 |
|
|
2019
Q2 | $3K | Hold |
666
| – | – | ﹤0.01% | 6512 |
|
|
2019
Q1 | $4K | Sell |
666
-33
| -5% | -$213 | ﹤0.01% | 6374 |
|
|
2018
Q4 | $4K | Sell |
699
-926
| -57% | -$7.03K | ﹤0.01% | 6268 |
|
|
2018
Q3 | $16K | Buy |
1,625
+959
| +144% | +$9.67K | ﹤0.01% | 5797 |
|
|
2018
Q2 | $7K | Sell |
666
-363
| -35% | -$4.11K | ﹤0.01% | 5955 |
|
|
2018
Q1 | $14K | Buy |
1,029
+863
| +520% | +$12.8K | ﹤0.01% | 5599 |
|
|
2017
Q4 | $3K | Sell |
166
-1,899
| -92% | -$39.6K | ﹤0.01% | 6223 |
|
|
2017
Q3 | $52K | Buy |
2,065
+1,863
| +922% | +$43.4K | ﹤0.01% | 5388 |
|
|
2017
Q2 | $4K | Sell |
202
-696
| -78% | -$15.4K | ﹤0.01% | 6140 |
|
|
2017
Q1 | $18K | Buy |
898
+49
| +6% | +$772 | ﹤0.01% | 5689 |
|
|
2016
Q4 | $13K | Sell |
849
-17
| -2% | -$221 | ﹤0.01% | 5983 |
|
|
2016
Q3 | $11K | Buy |
866
+700
| +422% | +$9.28K | ﹤0.01% | 5759 |
|
|
2016
Q2 | $2K | Hold |
166
| – | – | ﹤0.01% | 6173 |
|
|
2016
Q1 | $3K | Sell |
166
-17
| -9% | -$260 | ﹤0.01% | 6069 |
|
|
2015
Q4 | $3K | Sell |
183
-397
| -68% | -$7.58K | ﹤0.01% | 6304 |
|
|
2015
Q3 | $11K | Sell |
580
-121
| -17% | -$3.02K | ﹤0.01% | 5857 |
|
|
2015
Q2 | $18K | Buy |
+701
| New | +$19.9K | ﹤0.01% | 5759 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 6209 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6310 |
|
Royal Bank of Canada's PRTK Position: Q3 2023 in Review
Royal Bank of Canada sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 4,776 shares — an estimated $10K sold.
Royal Bank of Canada first reported a position in PRTK in Q2 2015 and held it in 33 quarters. The position peaked at $54K in Q4 2021. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Royal Bank of Canada reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Royal Bank of Canada sold 4,776 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $10K.
- Royal Bank of Canada first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 33 quarters.
- Royal Bank of Canada's Paratek Pharmaceuticals, Inc. position peaked at $54K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.